Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuralgia × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 70 Neoplasms, Plasma Cell 23 Neoplasms 12 Brain Neoplasms 11 Central Nervous System Neoplasms 10 Prostatic Neoplasms 9 Melanoma 8 Leukemia 8 Glioblastoma 8 Gliosarcoma 7 Glioma 7 Leukemia, Lymphocytic, Chronic, B-Cell 5 Waldenstrom Macroglobulinemia 4 Sarcoma 4 Recurrence 4 Myeloproliferative Disorders 4 Myelodysplastic Syndromes 4 Lymphoma, Mantle-Cell 4 Lymphoma, B-Cell, Marginal Zone 4 Lung Neoplasms 4 Immunoglobulin Light-chain Amyloidosis 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Oligodendroglioma 3 Neuroblastoma 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Carcinoma, Ovarian Epithelial 3 Astrocytoma 3

Interventions

Lidocaine 4 Oxycodone 2 ziconotide 1 nabiximols 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Transcutaneous Electric Nerve Stimulation 1 Transcranial Magnetic Stimulation 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Surveys and Questionnaires 1 Sodium Chloride 1 Pregabalin 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Manipulation, Osteopathic 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hypnosis 1 Hydromorphone 1 Geritol 1 Gabapentin 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00284505 2008-12-05

Use of Thalidomide in Patients With Arachnoiditis

Washington University School of Medicine

Phase 2 Completed

Arachnoiditis, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡